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Background
Anaphylaxis is a severe manifestation of IgE mediated
food allergy. There are few reports considering anaphy-
laxis in infants, a group where diagnosis and adequate
management can be difficult. The aim of the study was to
describe the clinical and laboratorial features of infants
with cow’s milk allergy (CMA) who had anaphylaxis.
Methods
It was a retrospective study, including CMA patients
who had anaphylaxis episodes before 2 years of age.
Definition of anaphylaxis was according to the criteria
proposed by Sampson et al, 2006. ImmunoCAP(Ther-
moFisher) was used for specific IgE analysis, and
patients with values > 0.35kU/L were considered
sensitized.
Results
It was included 51 infants (31 M) with median age of
first anaphylaxis episode at 6 mo (range 0.03-20 mo).
Criterion 1 was the most prevalent (36 patients) at ana-
phylaxis diagnosis followed by criterion 2 (15 patients).
Fresh milk was the trigger in 39 patients and dairy pro-
ducts in 12. Anaphylaxis was the first manifestation of
CMA in 36 patients. There was recurrence of episodes
in 37 patients, and in 46% it was related to intentional
exposure. Many parents were unaware of the initial
treatment of anaphylaxis (n = 19), 5 reported sponta-
neous resolution, but few parents reported use of par-
enteral medication (n=19) and only 5 informed that
epinephrine was administered. Specific IgE to cow’s milk
was positive in 45/48 with a median of 13.4 kU/L (0.35
to 100 kU/L). Among three patients with ImmunoCAP
to milk below 0.35, two had positive results in the
second blood sample and the other had positive prick
test. Positivity for casein occurred in 43 patients ranging
from 0.35 to 100 (median 12.5 KU/L).
Conclusion
Anaphylaxis can be a precocious manifestation of CMA
and early recognition of this severe event was still
undervalued by professionals and family members, with
high recurrence rates. There was a reduced use of epi-
nephrine, possibly as a consequence of lack of anaphy-
laxis identification or unknown of epinephrine as a first
choice drug in anaphylaxis. Education strategies should
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